SQUAMOUS CELL RECTAL CANCER
Clinical trials for SQUAMOUS CELL RECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL RECTAL CANCER trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL RECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy targets Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of three drugs—bintrafusp alfa, PDS01ADC, and entinostat—in adults with advanced HPV-related cancers (like cervical, anal, or throat cancer) or certain colon cancers that haven't responded to standard treatment. The goal is to find a safe dose and s…
Matched conditions: SQUAMOUS CELL RECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New HPV vaccine combo aims to fight Hard-to-Treat cancers
Disease control OngoingThis study tests an HPV vaccine (PRGN-2009) alone or with a drug called M7824 in people with HPV-positive cancers like cervical, anal, and throat cancers. The goal is to find a safe dose and see if the combination boosts the immune system's attack on tumors. The trial includes 39…
Matched conditions: SQUAMOUS CELL RECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC